{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:24:29Z","timestamp":1769855069922,"version":"3.49.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Coronavirus disease- (COVID-19-) related renal function abnormality is associated with poor prognosis. However, the clinical significance of dynamic changes in renal function indicators has not been studied, and no studies have evaluated the renal function in COVID-19 patients by cystatin C.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> This study aimed to evaluate the effect of abnormal renal function on admission on prognosis of COVID-19 patients and the prognostic value of various renal function indicators.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 1,764 COVID-19 patients without a history of chronic kidney disease were categorized into two groups, an elevated cystatin C group and a normal cystatin C group, based on the results of renal function tests on admission. The clinical characteristics were compared between the two groups, and logistic or Cox regression analyses were performed to explore the associations between elevated cystatin C\/serum creatinine levels and disease severity and survival. We also performed receiver operating characteristic (ROC) curve, Kaplan\u2013Meier survival, and curve fitting analyses.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> When adjusted for several significant clinical variables, elevated cystatin C levels on admission were independent predictors of disease severity (<jats:italic>p<\/jats:italic> &amp;lt; 0.001), and elevated creatinine levels were independent predictors of death (<jats:italic>p<\/jats:italic> = 0.020). Additionally, the ROC curve analysis shows that elevated cystatin C levels [area under the curve (AUC): 0.656] have a better predictive value for disease severity than elevated creatinine levels (AUC: 0.540). The survival curves of patients with elevated cystatin C\/creatinine levels show a sharper decline than those of patients with normal cystatin C\/creatinine levels (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The curve fitting analysis revealed that, compared to the flat curves of cystatin C and creatinine levels for patients who survived, the curves for patients who died kept rising, and cystatin C levels rose above the normal range earlier than creatinine.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Elevated cystatin C, which occurs earlier than serum creatinine, is useful for the early detection of renal function abnormality and might have better predictive value for disease severity in COVID-19 patients, while elevated serum creatinine may have a better predictive value for risks of death.<\/jats:p>","DOI":"10.3389\/fphar.2021.587816","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T06:59:43Z","timestamp":1616396383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Sichao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2214\/ajr.14.13021","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings","volume":"203","author":"Ajlan","year":"2014","journal-title":"Am. J. Roentgenol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/0886022x.2020.1756323","article-title":"Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis","volume":"42","author":"Ali","year":"2020","journal-title":"Ren. Fail."},{"key":"B3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc034","article-title":"Management of acute kidney injury in COVID-19","author":"Hassanein","year":"2020","journal-title":"Cleve. Clin. J. Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"106024","DOI":"10.1016\/j.ijantimicag.2020.106024","article-title":"Extra-respiratory manifestations of COVID-19","volume":"56","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.22.20075416","article-title":"Development and validation of a survival calculator for hospitalized patients with COVID-19","author":"Levy","year":"2020","journal-title":"medRxiv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.08.20021212","article-title":"Caution on kidney dysfunctions of COVID-19 patients","author":"Li","year":"2020","journal-title":"medRxiv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.34172\/jnp.2020.21","article-title":"COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection","volume":"9","author":"Mubarak","year":"2020","journal-title":"J. Nephropathol."},{"key":"B11","unstructured":"Guidelines for the diagnosis and treatment of COVID-19 (trial version 7)2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.acc.2014.11.007","article-title":"Cystatin C: a kidney function biomarker","volume":"68","author":"Onopiuk","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1148\/radiol.2303030853","article-title":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients","volume":"230","author":"Ooi","year":"2004","journal-title":"Radiology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","volume":"46","author":"Pan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"m1963","DOI":"10.1136\/bmj.m1963","article-title":"Covid-19 and acute kidney injury in hospital: summary of NICE guidelines","volume":"369","author":"Selby","year":"2020","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B18","unstructured":"Weekly epidemiological updates-19 january 20212021"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1093\/cid\/ciaa793","article-title":"Identification and validation of a novel clinical signature to predict the prognosis in confirmed COVID-19 patients","volume":"71","author":"Wu","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.7150\/thno.45016","article-title":"CT scans of patients with 2019 novel coronavirus (COVID-19) pneumonia","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.587816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T06:59:48Z","timestamp":1616396388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.587816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":21,"alternative-id":["10.3389\/fphar.2021.587816"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.587816","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"article-number":"587816"}}